CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma

BACKGROUND: The incidence and mortality of clear cell carcinoma of the kidney increases yearly. There are limited screening methods and advances in treating kidney renal clear cell carcinoma (KIRC). It is important to find new biomarkers to screen, diagnose and predict the prognosis of KIRC. Some st...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Lv, Wang, Yiming, Zhang, Zhiyuan, Feng, Xuechao, Xiao, Fengjun, Zong, Minru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656955/
https://www.ncbi.nlm.nih.gov/pubmed/37980541
http://dx.doi.org/10.1186/s40001-023-01487-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656955/
https://www.ncbi.nlm.nih.gov/pubmed/37980541
http://dx.doi.org/10.1186/s40001-023-01487-8

Ejemplares similares